• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症诊断工作中的“更好的解释”:一项为期 3 年的纵向研究。

"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study.

机构信息

From the Departments of Neuroscience, Biomedicine and Movement (M.C., A. Gajofatto) and Neurological and Movement Sciences (G.S.), University of Verona; Department of Neurosciences (C.G., C.T.), Azienda Ospedaliera San Camillo Forlanini, Roma; Department of Basic Medical Sciences, Neurosciences and Sense Organs (C.T., D.P.), University of Bari; Policlinico Gemelli (G.F.), Rome; Dipartimento di Biomedicina Sperimentale e Neuroscienze Cliniche (BIONEC) (P.R.), Università di Palermo; Istituto Neurologico Mediterraneo (R.F.), Pozzilli; Department of Neurology and Psychiatry (L.P.), Sapienza University of Rome; Multiple Sclerosis Center (P.A.), ASST Valle Olona, PO di Gallarate; Multiple Sclerosis Center (C.C.), Ospedale di Montichiari, Spedali Civili di Brescia; Clinica Neurologica (M.D.), Dipartimento di Medicina, Università di Perugia; Department of Biomedical, Metabolic and Neurosciences (D.F.), University of Modena and Reggio Emilia, Modena; Neurologia 2-CRESM (S.M.), AOU San Luigi Gonzaga, Orbassano; Multiple Sclerosis Centre (S.L.), A.O.U. Policlinico-Vittorio Emanuele, Catania; Neurology Clinic (G.D.), Multiple Sclerosis Center, SS. Annunziata Hospital, Chieti; Department of Medicine, Surgery and Neuroscience (M.L.S.), University of Siena; Department of Medical Science and Public Health (E.C.), University of Cagliari; Department of Medical, Surgical, Neurological, Metabolic and Aging Science (A. Gallo), University of Campania; Department of Neuroscience, Reproductive Sciences (R.L.), University Federico II, Naples, Italy; Institute of Psychological Medicine and Clinical Neurosciences (V.T.), Cardiff University School of Medicine, UK; Ospedale di Vaio (I.P.), Centro SM, Fidenza, Parma; Ospedale San Raffaele (M.E.R.), Milan; and Department of Rehabilitation (C.S.), Mons L Novarese Hospital, Moncrivello, Italy.

出版信息

Neurology. 2019 May 28;92(22):e2527-e2537. doi: 10.1212/WNL.0000000000007573. Epub 2019 May 1.

DOI:10.1212/WNL.0000000000007573
PMID:31043476
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC6659006/
Abstract

BACKGROUND

The exclusion of other diseases that can mimic multiple sclerosis (MS) is the cornerstone of current diagnostic criteria. However, data on the frequency of MS mimics in real life are incomplete.

METHODS

A total of 695 patients presenting with symptoms suggestive of MS in any of the 22 RIREMS centers underwent a detailed diagnostic workup, including a brain and spinal cord MRI scan, CSF and blood examinations, and a 3-year clinical and radiologic follow-up.

FINDINGS

A total of 667 patients completed the study. Alternative diagnoses were formulated in 163 (24.4%) cases, the most frequent being nonspecific neurologic symptoms in association with atypical MRI lesions of suspected vascular origin (40 patients), migraine with atypical lesions (24 patients), and neuromyelitis optica (14 patients). MS was diagnosed in 401 (60.1%) patients according to the 2017 diagnostic criteria. The multivariate analysis revealed that the absence of CSF oligoclonal immunoglobulin G bands (IgG-OB) (odds ratio [OR] 18.113), the presence of atypical MRI lesions (OR 10.977), the absence of dissemination in space (DIS) of the lesions (OR 5.164), and normal visual evoked potentials (OR 3.550) were all independent predictors of an alternative diagnosis.

INTERPRETATION

This observational, unsponsored, real-life study, based on clinical practice, showed that diseases that mimicked MS were many, but more than 45% were represented by nonspecific neurologic symptoms with atypical MRI lesions of suspected vascular origin, migraine, and neuromyelitis optica. The absence of IgG-OB and DIS, the presence of atypical MRI lesions, and normal visual evoked potentials should be considered suggestive of an alternative disease and red flags for the misdiagnosis of MS.

摘要

背景

排除其他可模仿多发性硬化症(MS)的疾病是当前诊断标准的基石。然而,关于真实生活中 MS 模拟物的频率的数据并不完整。

方法

共有 695 名在 22 个 RIREMS 中心出现任何 MS 症状的患者接受了详细的诊断检查,包括脑和脊髓 MRI 扫描、CSF 和血液检查,以及 3 年的临床和放射学随访。

结果

共有 667 名患者完成了研究。在 163 例(24.4%)病例中制定了替代诊断,最常见的是伴有可疑血管源性非典型 MRI 病变的非特异性神经系统症状(40 例)、伴有非典型病变的偏头痛(24 例)和视神经脊髓炎(14 例)。根据 2017 年的诊断标准,401 例(60.1%)患者诊断为 MS。多变量分析显示,CSF 寡克隆免疫球蛋白 G 带(IgG-OB)缺失(优势比 [OR] 18.113)、存在非典型 MRI 病变(OR 10.977)、病变空间分布不扩散(OR 5.164)和正常视觉诱发电位(OR 3.550)均为替代诊断的独立预测因素。

解释

这项基于临床实践的观察性、无赞助的真实生活研究表明,模仿 MS 的疾病很多,但超过 45%是由非特异性神经系统症状、疑似血管源性非典型 MRI 病变、偏头痛和视神经脊髓炎引起的。IgG-OB 缺失和 DIS 缺失、存在非典型 MRI 病变和正常视觉诱发电位应被视为提示替代疾病的指标,并提示 MS 误诊的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb1f/6659006/28d120fb9778/NEUROLOGY2018930495FF1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb1f/6659006/28d120fb9778/NEUROLOGY2018930495FF1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb1f/6659006/28d120fb9778/NEUROLOGY2018930495FF1.jpg

相似文献

1
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study.多发性硬化症诊断工作中的“更好的解释”:一项为期 3 年的纵向研究。
Neurology. 2019 May 28;92(22):e2527-e2537. doi: 10.1212/WNL.0000000000007573. Epub 2019 May 1.
2
Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study.临床孤立综合征向多发性硬化症的转化:一项前瞻性研究。
Mult Scler Relat Disord. 2020 Sep;44:102262. doi: 10.1016/j.msard.2020.102262. Epub 2020 Jun 4.
3
The role of MRI in the diagnosis of multiple sclerosis.磁共振成像在多发性硬化诊断中的作用。
Adv Neurol. 2006;98:125-46.
4
The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis.脑脊液寡克隆区带对多发性硬化早期诊断的贡献。
Mult Scler. 2009 Apr;15(4):472-8. doi: 10.1177/1352458508100502. Epub 2009 Jan 19.
5
Added value of optic nerve lesions for multiple sclerosis diagnostic criteria.视神经病变对多发性硬化诊断标准的附加价值。
J Neurol. 2025 Apr 24;272(5):358. doi: 10.1007/s00415-025-13036-w.
6
Investigating Whether Dissemination in Time Is Essential to Diagnose Relapsing Multiple Sclerosis.研究时间上的传播对于诊断复发型多发性硬化症是否至关重要。
Neurology. 2025 Apr 8;104(7):e210274. doi: 10.1212/WNL.0000000000210274. Epub 2025 Mar 4.
7
Failure to develop multiple sclerosis in patients with neurologic symptoms without objective evidence.在没有客观证据的情况下,患有神经系统症状的患者未发展为多发性硬化症。
Mult Scler. 2008 Jul;14(6):804-8. doi: 10.1177/1352458507088156. Epub 2008 Jun 23.
8
Brain abnormalities in neuromyelitis optica.视神经脊髓炎中的脑异常。
Arch Neurol. 2006 Mar;63(3):390-6. doi: 10.1001/archneur.63.3.390.
9
[The diagnostic value of nuclear magnetic resonance tomography, multimodal evoked potentials and cerebrospinal fluid examination in multiple sclerosis].[磁共振断层扫描、多模态诱发电位及脑脊液检查在多发性硬化症中的诊断价值]
Nervenarzt. 1993 Apr;64(4):226-32.
10
MRI mimics of multiple sclerosis.多发性硬化的磁共振成像(MRI)模拟病变
Handb Clin Neurol. 2014;122:291-316. doi: 10.1016/B978-0-444-52001-2.00012-1.

引用本文的文献

1
7 Tesla MRI in Multiple Sclerosis: Insights From Its Use in Clinical Routine.7特斯拉磁共振成像在多发性硬化症中的应用:临床常规使用的见解
Eur J Neurol. 2025 Aug;32(8):e70330. doi: 10.1111/ene.70330.
2
Multiple sclerosis diagnosis and its differential diagnosis in patients presenting with type four 'mirror pattern' CSF oligoclonal bands.出现4型“镜像模式”脑脊液寡克隆带患者的多发性硬化症诊断及其鉴别诊断
J Neurol. 2025 Feb 15;272(3):207. doi: 10.1007/s00415-025-12947-y.
3
Consensus-Based Guidelines for Communicating a Misdiagnosis of Multiple Sclerosis to Reduce Psychological Distress.

本文引用的文献

1
Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice.多发性硬化症的误诊:2017 年麦当劳标准对临床实践的影响。
Neurology. 2019 Jan 1;92(1):26-33. doi: 10.1212/WNL.0000000000006583. Epub 2018 Oct 31.
2
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes.2017 年 McDonald 标准修订版缩短了临床孤立综合征患者多发性硬化症的诊断时间。
J Neurol. 2018 Nov;265(11):2684-2687. doi: 10.1007/s00415-018-9048-8. Epub 2018 Sep 8.
3
The current role of MRI in differentiating multiple sclerosis from its imaging mimics.
基于共识的多发性硬化症误诊沟通指南,以减轻心理困扰。
Brain Behav. 2024 Oct;14(10):e70109. doi: 10.1002/brb3.70109.
4
Fluid biomarkers in multiple sclerosis: from current to future applications.多发性硬化症中的流体生物标志物:从当前应用到未来应用
Lancet Reg Health Eur. 2024 Aug 22;44:101009. doi: 10.1016/j.lanepe.2024.101009. eCollection 2024 Sep.
5
The prevalence of multiple sclerosis in Israel based on validation of a health care organization database.基于对医疗保健组织数据库的验证,以色列多发性硬化症的流行情况。
Sci Rep. 2024 Oct 23;14(1):25070. doi: 10.1038/s41598-024-76282-4.
6
Headache in Multiple Sclerosis: A Narrative Review.多发性硬化症中的头痛:一篇叙述性综述。
Medicina (Kaunas). 2024 Mar 30;60(4):572. doi: 10.3390/medicina60040572.
7
The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis.多发性硬化症伴或不伴寡克隆带的脑脊液免疫特征:一种接近延伸分析的机器学习方法。
Int J Mol Sci. 2023 Dec 21;25(1):139. doi: 10.3390/ijms25010139.
8
Absence of Oligoclonal Bands in Multiple Sclerosis: A Call for Differential Diagnosis.多发性硬化症中寡克隆带缺失:呼吁进行鉴别诊断。
J Clin Med. 2023 Jul 13;12(14):4656. doi: 10.3390/jcm12144656.
9
The radiologically isolated syndrome: revised diagnostic criteria.放射学孤立综合征:修订后的诊断标准。
Brain. 2023 Aug 1;146(8):3431-3443. doi: 10.1093/brain/awad073.
10
Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement.脑脊液生物标志物在多发性硬化症和累及中枢神经系统的全身性炎症性疾病鉴别诊断中的应用
Biomedicines. 2023 Feb 1;11(2):425. doi: 10.3390/biomedicines11020425.
磁共振成像在鉴别多发性硬化与其影像模拟疾病中的当前作用。
Nat Rev Neurol. 2018 Mar 20;14(4):213. doi: 10.1038/nrneurol.2018.39.
4
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.国际头痛协会(IHS)头痛分类委员会《国际头痛疾病分类》第三版
Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202.
5
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.多发性硬化症的诊断:2017 年麦当劳标准修订版。
Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21.
6
New guidelines for the diagnosis of fibromyalgia.纤维肌痛诊断新指南。
Rev Bras Reumatol Engl Ed. 2017;57 Suppl 2:467-476. doi: 10.1016/j.rbre.2017.07.002. Epub 2017 Aug 8.
7
Diagnostic criteria for Susac syndrome.Susac 综合征的诊断标准。
J Neurol Neurosurg Psychiatry. 2016 Dec;87(12):1287-1295. doi: 10.1136/jnnp-2016-314295. Epub 2016 Oct 25.
8
Diagnosis of multiple sclerosis: progress and challenges.多发性硬化症的诊断:进展与挑战。
Lancet. 2017 Apr 1;389(10076):1336-1346. doi: 10.1016/S0140-6736(16)30959-X. Epub 2016 Nov 24.
9
2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts.2016 年美国风湿病学会/欧洲抗风湿病联盟原发性干燥综合征分类标准:一项涉及三个国际患者队列的共识和数据驱动方法。
Ann Rheum Dis. 2017 Jan;76(1):9-16. doi: 10.1136/annrheumdis-2016-210571. Epub 2016 Oct 26.
10
The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.多发性硬化误诊的当代谱:一项多中心研究。
Neurology. 2016 Sep 27;87(13):1393-9. doi: 10.1212/WNL.0000000000003152. Epub 2016 Aug 31.